Projects per year
Fingerprint Dive into the research topics where Richard Geoffrey Vile is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Neoplasms
Medicine & Life Sciences
Oncolytic Viruses
Medicine & Life Sciences
Genetic Therapy
Medicine & Life Sciences
Immunotherapy
Medicine & Life Sciences
Melanoma
Medicine & Life Sciences
Viruses
Medicine & Life Sciences
Vesicular Stomatitis
Medicine & Life Sciences
Oncolytic Virotherapy
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1980 2019
Enhancing Therapy of Primary and Recurrent Tumors With Systemic Oncolytic Virus
5/7/14 → 4/30/19
Project: Research project
Oncolytic Viruses
Neoplasms
Therapeutics
Paclitaxel
Oncolytic Virotherapy
Enhancing Systemic Delivery of Oncolytic Viruses for Cancer Therapy
1/1/09 → 11/30/14
Project: Research project
Oncolytic Virotherapy
Viruses
Neoplasms
Oncolytic Viruses
Vesicular Stomatitis
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
7/1/08 → 5/31/14
Project: Research project
Melanocytes
Autoimmunity
Immunity
Melanoma
Neoplasms
Oncolytic Viruses
T-Lymphocytes
Genetic Therapy
Neoplasms
Viruses
Research Output 1989 2019
Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity
Schuelke, M. R., Wongthida, P., Thompson, J., Kottke, T., Driscoll, C. B., Huff, A. L., Shim, K. G., Coffey, M., Pulido, J. S., Evgin, L. & Vile, R. G., Jul 17 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 188.Research output: Contribution to journal › Article
Open Access
Brain Stem Neoplasms
Immunotherapy
Brain Stem
Neoplasms
Pediatrics
2
Citations
(Scopus)
Phase I trial of an ICAM-1-targeted immunotherapeutic-coxsackievirus A21 (CVA21) as an oncolytic agent against non muscle-invasive bladder cancer
Annels, N. E., Mansfield, D., Arif, M., Ballesteros-Merino, C., Simpson, G. R., Denyer, M., Sandhu, S. S., Melcher, A. A., Harrington, K. J., Davies, B., Au, G., Grose, M., Bagwan, I., Fox, B., Vile, R., Mostafid, H., Shafren, D. & Pandha, H. S., Jan 1 2019, In : Clinical Cancer Research. 25, 19, p. 5818-5831 14 p.Research output: Contribution to journal › Article
Enterovirus
Intercellular Adhesion Molecule-1
Urinary Bladder Neoplasms
Muscles
Mitomycin
1
Citation
(Scopus)
Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition
Jennings, V. A., Scott, G. B., Rose, A. M. S., Scott, K. J., Migneco, G., Keller, B., Reilly, K., Donnelly, O., Peach, H., Dewar, D., Harrington, K. J., Pandha, H., Samson, A., Vile, R. G., Melcher, A. A. & Errington-Mais, F., Jan 1 2019, In : Molecular Therapy.Research output: Contribution to journal › Article
Open Access
Oncolytic Viruses
Histone Deacetylases
Granulocyte-Macrophage Colony-Stimulating Factor
Simplexvirus
Natural Killer Cells
1
Citation
(Scopus)
Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment
Evgin, L., Huff, A. L., Kottke, T., Thompson, J., Molan, A. M., Driscoll, C. B., Schuelke, M., Shim, K. G., Wongthida, P., Ilett, E. J., Smith, K. K., Harris, R. S., Coffey, M., Pulido, J. S., Pandha, H., Selby, P. J., Harrington, K. J., Melcher, A. & Vile, R. G., May 1 2019, In : Cancer Immunology Research. 7, 5, p. 828-840 13 p.Research output: Contribution to journal › Article
Cell- and Tissue-Based Therapy
T-Lymphocytes
Phenotype
Neoplasms
Genetic Therapy
6
Citations
(Scopus)
Ad5NULL-A20: A tropism-modified, avb6 integrin-selective oncolytic adenovirus for epithelial ovarian cancer therapies
Uusi-Kerttula, H., Davies, J. A., Thompson, J. M., Wongthida, P., Evgin, L., Shim, K. G., Bradshaw, A., Baker, A. T., Rizkallah, P. J., Jones, R., Hanna, L., Hudson, E., Vile, R. G., Chester, J. D. & Parker, A. L., Sep 1 2018, In : Clinical Cancer Research. 24, 17, p. 4215-4224 10 p.Research output: Contribution to journal › Article
Tropism
Adenoviridae
Integrins
Neoplasms
Transgenes